“…There is strong evidence associating hyporeactivity with SSD and disease progression (Javitt et al, 2018; Koshiyama et al, 2020). Hyporeactive neural responses in SSD are cataloged across a variety of measures, including preconscious deviance detection (mismatch negativity: MMN) in visual (Farkas et al, 2015; Urban et al, 2008) and auditory domains (Erickson et al, 2016; Haigh, Coffman, et al, 2016; Joshi et al, 2018; Koshiyama et al, 2020; Umbricht & Krljes, 2005), and reduced N1 responses to visual (Antonova et al, 2021; Hoptman et al, 2018; Neuhaus et al, 2011) and auditory stimuli (Force et al, 2008; Mathalon et al, 2019; Osokina & Ivnyev, 2018; Perez et al, 2012). Hyporeactive BOLD responses in fMRI designs are observed in early visual, auditory, and somatosensory cortices (Gaebler et al, 2015; Haenschel et al, 2007; Haigh, Gupta, et al, 2016; Hoptman et al, 2010; Martínez et al, 2018).…”